NYSE · HUM

Humana Inc.

$381.15 -$8.17 (-2.10%) 1D Pre-market

Key Metrics

$46.74B
Market cap
41.36×
P/E · TTM
$137.20B
Revenue · TTM
$1.13B
Net income
EPS · TTM $9.35
Dividend yield 0.9%
Free cash flow $1.27B
Beta · 1Y 0.50
EBITDA · TTM $1.93B
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 8
    The stock moved +11.3% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 8

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$46.74B
Enterprise value$38.14B
Shares outstanding120.1M
52-wk range$163.11 – $428.88
Avg volume · 20D1.4M
Net cash $8.60B
Book value / share$153.75
IndustryHospital & Medical Service Plans
ExchangeNYSE
About Humana Inc.
IPO dateMay 18, 1971
Employees67060

Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E41.36
P/S0.34
P/FCF36.75
EV/EBITDA19.72
EV/Sales0.28
Graham №$179.86

Profitability

Gross
Operating 0.9%
Net 0.8%
FCF 0.9%
ROE / ROIC 6.5% · 9.1%

Financial Health

Current ratio1.77
Quick ratio
Debt / equity0.75
Debt / EBITDA 7.24
Net cash $8.60B
Working capital$16.57B

Cash Flow · TTM

Operating CF $1.84B
Capex −$572.00M
Free cash flow $1.27B
Buybacks $249.00M
Dividends paid $429.00M
Shareholder yield 1.5%

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

4.4
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

$179.86 vs $381.15
Trades 2.1× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings